The Oncology Institute, Inc.TOINASDAQ
Loading
Year-over-year SG&A expense growth
Latest
10.87%
↑ 641% vs avg
Percentile
P88
Within normal range
Streak
2 qtr
Consecutive growthStable
Average
-2.01%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 10.87% |
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | 2.08% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | -100.00% |
| Q3 2022 | 12.75% |
| Q2 2022 | -4.89% |
| Q1 2022 | -38.22% |
| Q4 2021 | 278.99% |
| Q3 2021 | 13.54% |
| Q2 2021 | 0.30% |
| Q1 2021 | -25.66% |
| Q4 2020 | 0.00% |
| Q3 2020 | -100.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2018 | 0.00% |